Advanced search
Publication Cover
Current Eye Research Volume 24, 2002 - Issue 5
Submit an article Journal homepage
47
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Protein Phosphatase 1 binds strongly to the retinoblastoma protein but not to p107 or p130 in vitro and in vivo

Joshua L. Dunaief FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
,
Ayala King FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
,
Noriko Esumi FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
,
Matthew Eagen FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
,
Tzvete Dentchev FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
,
Ching-Hwa Sung FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
,
Shiming Chen FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
&
Donald J. Zack FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA; Wilmer Eye Institute and Department of Molecular Biology & Genetics, and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Ophthalmology, Cell Biology and Anatomy, Cornell University School of Medicine, New York, NY, USA; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA
 show all
Pages 392-396 | Published online: 02 Jul 2009

References

  • Horowitz JM, Park SH, Bogenmann E, Cheng JC, Yandell DW, Kaye FJ, Minna JD, Dryja TP, Weinberg RA. Frequent inactivation of the retinoblastoma anti-oncogene is re-stricted to a subset of human tumor cells. Proc Nall Acad Sci USA. 1990;87:2775–2779.
  • Taya Y. RB kinases and RB-binding proteins: New points of view. Trends Biochem Sci. 1997;22:14–17.
  • Adams PD, Kaelin WG, Jr. Transcriptional control by E2F. Semin Cancer BioL 1995;6: 99–108.
  • Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 1994;79:119–130.
  • Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell. 1989;58:1097–1105.
  • Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein func-tions by ectopic expression of human cyclins. Cell. 1992;70:993–1006.
  • Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell. 1991;67: 293–302.
  • Kumar R, Chen S, Scheurer D, Wang QL, Duh E, Sung CH, Rehemtulla A, Swaroop A, Adler R, Zack DJ. The bZIP transcription factor Nrl stimulates rhodopsin promoter activity in primary retinal cell cultures. J Biol Chem. 1996;271:29612–29618.
  • Tai AW, Chuang JZ, Bode C, Wolfrum U, Sung CH. Rhodopsin's carboxy-terminal cytoplasmic tail acts as a membrane receptor for cytoplasmic dynein by binding to the dynein light chain Tctex-1. Cell. 1999;97: 877–887.
  • Strober BE, Dunaief JL, Guha, Goff SP. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell BioL 1996;16:1576–1583.
  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75: 805–816.
  • Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ. The retinoblastoma protein asso-ciates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 1993;7:555–569.
  • Nelson DA, Krucher NA, Ludlow JIM High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein. J Biol Chem. 1997;272:4528–4535.
  • Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323–330.
  • Phelps WC, Munger K, Yee CL, Barnes JA, Howley PM. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J ViroL 1992;66: 2418–2427.
  • Jones RE, Wegrzyn RI, Patrick DR, Balishin NL, Vuocolo GA, Riemen MW, Defeo-Jones D, Garsky VM, Heimbrook DC, Oliff A. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma sup-pressor protein. J Biol Chem. 1990;265: 12782–12785.
  • Voorhoeve PM, Hijmans EM, Bernards R. Functional inter-action between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene. 1999;18: 515–524.
  • Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155–169.
  • Tamrakar S, Ludlow JAM The carboxyl-terminal region of the retinoblastoma protein binds non-competitively to protein phosphatase type lalpha and inhibits catalytic activ-ity. J Biol Chem. 2000;275:27784–27789.
  • Wang RH, Liu CW, Avramis VI, Berndt N. Protein phosphatase 1 alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene. 2001;20:6111–6122.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.